These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21890289)

  • 1. Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density.
    Dubnov-Raz G; Hemilä H; Vurembrand Y; Kuint J; Maayan-Metzger A
    Early Hum Dev; 2012 Mar; 88(3):191-4. PubMed ID: 21890289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning.
    Weaver SR; Xie C; Charles JF; Hernandez LL
    Sci Rep; 2019 Jan; 9(1):238. PubMed ID: 30659249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study.
    de Vries NK; van der Veere CN; Reijneveld SA; Bos AF
    PLoS One; 2013; 8(5):e64654. PubMed ID: 23785389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does fetal exposure to SSRIs or maternal depression impact infant growth?
    Wisner KL; Bogen DL; Sit D; McShea M; Hughes C; Rizzo D; Confer A; Luther J; Eng H; Wisniewski SW
    Am J Psychiatry; 2013 May; 170(5):485-93. PubMed ID: 23511234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study Evaluating the Effects of SSRI Exposure on Cardiac Size and Function in Newborns.
    Ansah DA; Reinking BE; Colaizy TT; Roghair RD; Haskell SE
    Neonatology; 2019; 115(4):320-327. PubMed ID: 30836356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
    Laine K; Heikkinen T; Ekblad U; Kero P
    Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior.
    Zeskind PS; Stephens LE
    Pediatrics; 2004 Feb; 113(2):368-75. PubMed ID: 14754951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
    Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
    Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
    Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
    Knickmeyer RC; Meltzer-Brody S; Woolson S; Hamer RM; Smith JK; Lury K; Gilmore JH
    Neuropsychopharmacology; 2014 Oct; 39(11):2611-21. PubMed ID: 24837031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
    Lund N; Pedersen LH; Henriksen TB
    Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.
    Davidson S; Prokonov D; Taler M; Maayan R; Harell D; Gil-Ad I; Weizman A
    Pediatr Res; 2009 Feb; 65(2):236-41. PubMed ID: 19262294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.